# OnCo record da-pair-lecanemab-mri (pairing). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/pairings/da-pair-lecanemab-mri/>
  a schema:MedicalTherapy ;
  onco:kind "pairing" ;
  schema:identifier "da-pair-lecanemab-mri" ;
  schema:name "Lecanemab with MRI monitoring"@en ;
  schema:description "Amyloid antibodies are used with scheduled MRI checks for ARIA, not as a standalone infusion without imaging follow-up."@en ;
  schema:url <https://onco.cc/pairings/da-pair-lecanemab-mri/> ;
  schema:dateModified "2026-09-21"^^xsd:date ;
  schema:citation <https://www.fda.gov/news-events/press-announcements/fda-converts-novel-alzheimers-disease-treatment-traditional-approval> ;
  onco:tag "dementia-atlas" ;
  onco:cancers <https://onco.cc/diagnoses/alzheimers-disease/> ;
  onco:technologies <https://onco.cc/technologies/da-tech-mri/> ;
  onco:drugs <https://onco.cc/drugs/da-lecanemab/> ;
  onco:terms <https://onco.cc/terms/da-term-aria/> ;
  onco:pairs <https://onco.cc/drugs/da-lecanemab/>, <https://onco.cc/technologies/da-tech-mri/> .